Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
3,533,711
-
Share change
-
-585,450
-
Total reported value
-
$12,193,010
-
Price per share
-
$3.45
-
Number of holders
-
33
-
Value change
-
-$1,993,489
-
Number of buys
-
11
-
Number of sells
-
16
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2018
As of 30 Sep 2018,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,533,711 shares.
The largest 10 holders included
Vanguard Group Inc, Alethea Capital Management, LLC, Sio Capital Management, LLC, FMR LLC, STIFEL FINANCIAL CORP, ROYCE & ASSOCIATES LP, Opus Point Partners Management, LLC, Endurant Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.